HCW Biologics Inc. (HCWB)
HCW Biologics Statistics
Share Statistics
HCW Biologics has 2.41M shares outstanding. The number of shares has increased by -0.19% in one year.
| 2.41M |
| -0.19% |
| -0.19% |
| 8.27% |
| n/a |
| 392,910 |
| 59.93% |
Short Selling Information
The latest short interest is 288.44K, so 15% of the outstanding shares have been sold short.
| 288.44K |
| 15% |
| 19.6% |
| 1 |
Valuation Ratios
The PE ratio is -23.05 and the forward PE ratio is -1.23. HCW Biologics's PEG ratio is -2.31.
| -23.05 |
| -1.23 |
| 269.62 |
| 90.9 |
| -102.22 |
| -47.76 |
| -2.31 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for HCW Biologics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 0.19, with a Debt / Equity ratio of -2.02.
| 0.19 |
| 0.19 |
| -2.02 |
| -0.49 |
| -0.95 |
| -25.45 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $71,299.78 |
| $-833,994.83 |
| 36 |
| 0.08 |
| n/a |
Taxes
| n/a |
| 0% |
Stock Price Statistics
The stock price has increased by -84.69% in the last 52 weeks. The beta is 0.83, so HCW Biologics's price volatility has been higher than the market average.
| 0.83 |
| -84.69% |
| 8.5 |
| 15.69 |
| 36.95 |
| 655,566 |
Income Statement
In the last 12 months, HCW Biologics had revenue of 2.57M and earned -30.02M in profits. Earnings per share was -0.77.
| 2.57M |
| 959.4K |
| -29.48M |
| -30.02M |
| -27.68M |
| -28.87M |
| -0.77 |
Balance Sheet
The company has 4.67M in cash and 13.69M in debt, giving a net cash position of -9.02M.
| 4.67M |
| 13.69M |
| -9.02M |
| -100.56M |
| 26.29M |
| -25.25M |
Cash Flow
In the last 12 months, operating cash flow was -14.23M and capital expenditures -261.62K, giving a free cash flow of -14.49M.
| -14.23M |
| -261.62K |
| -14.49M |
| -0.37 |
Margins
Gross margin is 37.38%, with operating and profit margins of -1148.5% and -1169.7%.
| 37.38% |
| -1148.5% |
| -1169.7% |
| -1169.7% |
| -1078.43% |
| -1148.5% |
| -564.48% |
Dividends & Yields
HCWB does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for HCWB is $35, which is 444.3% higher than the current price. The consensus rating is "Buy".
| $35 |
| 444.3% |
| Buy |
| 1 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Stock Splits
The last stock split was on Apr 11, 2025. It was a backward split with a ratio of 1:40.
| Apr 11, 2025 |
| backward |
| 1:40 |
Scores
| -9.28 |
| 2 |